30 Jan 2024 BioLizard announces the appointment of André van de Sande as Chairman of the Board Member news
29 Jan 2024 Sequana Medical announces FDA acceptance for substantive review of the Premarket Approval application for alfapump® in recurrent or refractory ascites due to liver cirrhosis
23 Jan 2024 Sequana Medical announces DSMB approval to start randomized MOJAVE cohort – US Phase 1/2a study of DSR® 2.0 for treatment of heart failure Member news
23 Jan 2024 Protealis secures EUR 22 million in oversubscribed B-round funding to propel sustainable plant protein seed solutions Member news
17 Jan 2024 argenx announces approval of VYVDURA® (efgartigimod alfa and hyaluronidase-qvfc) injection for subcutaneous use in Japan for generalized myasthenia gravis Member news
17 Jan 2024 QbD Chair for Precision Oncology Research in Glioblastoma extended for three years Member news
16 Jan 2024 KU Leuven researchers discover how to break the negative feedback loop to improve cancer immunotherapy Member news
16 Jan 2024 Health & care incubator BioVille strengthens its position with additional 2,000m² wing Member news
More info? Ellen Telleir Communication Coordinator linkedin.com/in/ellentelleir/ +32 9 241 80 41 ellen.telleir@flanders.bio Contact us
